British Journal Of Cancer

British Journal Of Cancer

英国癌症杂志

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《British Journal Of Cancer》是由Springer Nature出版社于1947年创办的英文国际期刊(ISSN: 0007-0920,E-ISSN: 1532-1827),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.9862...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比87.69%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在390篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

British Journal Of Cancer审稿周期约为 约6月 。该刊近年未被列入国际预警名单,年发文量约390篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 390 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 46 / 322

85.9%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 44 / 322

86.49%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:15.1 SJR:3 SNIP:1.83
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 33 / 404

91%

大类:Medicine 小类:Cancer Research Q1 27 / 230

88%

期刊发文

  • PIK3CA mutations are associated with pathologic complete response rate to neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer

    Author: Shi, Qiyun; Xuhong, Juncheng; Luo, Tao; Ge, Jia; Liu, Feng; Lan, Yang; Chen, Qingqiu; Tang, Peng; Fan, Linjun; Chen, Li; Liang, Yan; Wang, Minghao; Hu, Ying; Zhang, Yi; Bian, Xiuwu; Qi, Xiaowei; Jiang, Jun

    Journal: BRITISH JOURNAL OF CANCER. 2023; Vol. 128, Issue 1, pp. 121-129. DOI: 10.1038/s41416-022-02021-z

  • Integrative analysis of multi-omics data for liquid biopsy

    Author: Chen, Geng; Zhang, Jing; Fu, Qiaoting; Taly, Valerie; Tan, Fei

    Journal: BRITISH JOURNAL OF CANCER. 2023; Vol. 128, Issue 4, pp. 505-518. DOI: 10.1038/s41416-022-02048-2

  • Evolving roles of CD38 metabolism in solid tumour microenvironment

    Author: Gao, Long; Du, Xiaohong; Li, Jiabin; Qin, F. Xiao-Feng

    Journal: BRITISH JOURNAL OF CANCER. 2023; Vol. 128, Issue 4, pp. 492-504. DOI: 10.1038/s41416-022-02052-6

  • IL-33/ST2 signaling promotes constitutive and inductive PD-L1 expression and immune escape in oral squamous cell carcinoma

    Author: Zhao, Mengxiang; He, Yijia; Zhu, Nisha; Song, Yuxian; Hu, Qingang; Wang, Zhiyong; Ni, Yanhong; Ding, Liang

    Journal: BRITISH JOURNAL OF CANCER. 2023; Vol. 128, Issue 5, pp. 833-843. DOI: 10.1038/s41416-022-02090-0

  • Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect

    Author: Liu, Senbo; Zhang, Yan; Liu, Yang; Wang, Wenkang; Gao, Shuochen; Yuan, Weitang; Sun, Zhenqiang; Liu, Lin; Wang, Chengzeng

    Journal: BRITISH JOURNAL OF CANCER. 2023; Vol. 128, Issue 5, pp. 715-725. DOI: 10.1038/s41416-022-02076-y

  • Association between dietary inflammatory potential and mortality after cancer diagnosis in the Women's Health Initiative

    Author: Zheng, Jiali; Tabung, Fred K.; Zhang, Jiajia; Caan, Bette; Hebert, James R.; Kroenke, Candyce H.; Ockene, Judith; Shivappa, Nitin; Steck, Susan E.

    Journal: BRITISH JOURNAL OF CANCER. 2023; Vol. 128, Issue 4, pp. 606-617. DOI: 10.1038/s41416-022-02079-9

  • All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RAR alpha-Nrf2 complex

    Author: Wang, Lu; Zhang, Qi; Ye, Li; Ye, Xingnong; Yang, Wenli; Zhang, Hua; Zhou, Xinping; Ren, Yanling; Ma, Liya; Zhang, Xiang; Mei, Chen; Xu, Gaixiang; Li, Kongfei; Luo, Yingwan; Jiang, Lingxu; Lin, Peipei; Zhu, Shuanghong; Lang, Wei; Wang, Yuxia; Shen, Chuying; Han, Yueyuan; Liu, Xiaozhen; Yang, Haiyang; Lu, Chenxi; Sun, Jie; Jin, Jie; Tong, Hongyan

    Journal: BRITISH JOURNAL OF CANCER. 2023; Vol. 128, Issue 4, pp. 691-701. DOI: 10.1038/s41416-022-02074-0

  • Molecular features and evolutionary trajectory of ASCL1(+) and NEUROD1(+) SCLC cells

    Author: Zhang, Xuexi; Wang, Hao; Liu, Wenxu; Xiao, Zengtuan; Ma, Zhenyi; Zhang, Zhenfa; Gong, Wenchen; Chen, Jun; Liu, Zhe

    Journal: BRITISH JOURNAL OF CANCER. 2023; Vol. 128, Issue 5, pp. 748-759. DOI: 10.1038/s41416-022-02103-y